Level Four Advisory Services’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,560
Closed -$445K 875
2023
Q2
$445K Buy
+1,560
New +$433K 0.03% 509
2023
Q1
Sell
-1,570
Closed -$323K 839
2022
Q4
$323K Sell
1,570
-3,102
-66% -$784K 0.02% 506
2022
Q3
$1.3M Buy
4,672
+606
+15% +$154K 0.13% 177
2022
Q2
$777K Sell
4,066
-360
-8% -$63.5K 0.07% 263
2022
Q1
$918K Buy
4,426
+773
+21% +$127K 0.07% 260
2021
Q4
$651K Buy
3,653
+1,258
+53% +$248K 0.05% 327
2021
Q3
$493K Buy
2,395
+936
+64% +$184K 0.05% 295
2021
Q2
$277K Buy
+1,459
New +$239K 0.02% 551

Other funds holding SWAV

Level Four Advisory Services's SWAV Position: Q3 2023 in Review

Level Four Advisory Services sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 1,560 shares — an estimated $445K sold.

Level Four Advisory Services first reported a position in SWAV in Q2 2021 and held it in 8 quarters. The position peaked at $1.3M in Q3 2022. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Level Four Advisory Services reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Level Four Advisory Services sold 1,560 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $445K.
  • Level Four Advisory Services first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Level Four Advisory Services's Shockwave Medical, Inc. Common Stock position peaked at $1.3M in Q3 2022.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Level Four Advisory Services's 13F filing for Q3 2023, filed 13 Nov 2023.